Navigation Links
Carl Zeiss Vision and Transitions Optical Inc. Promote Pioneering Eyewear to Consumers
Date:12/17/2008

The GT2™ by ZEISS Combines ZEISS's Precision Progressive Lenses and Transitions® Lenses to Produce Optimal Visual Experience

San Diego, CA (PRWEB) December 17, 2008 -- Two of the most distinguished names in the optical industry are collaborating to educate consumers about the latest in leading-edge eyewear.

Carl Zeiss Vision, a leader for 160 years in precision optics, and Transitions Optical Inc., maker of the #1 doctor-recommended photochromic lens, are promoting the OLA award winning GT2™ by ZEISS eyewear to consumers.

The ground-breaking lenses combine the unparalleled quality of ZEISS progressive lenses and Transitions® lenses, which are clear indoors and at night and darken outdoors depending on the intensity of the sun's ultraviolet rays.

GT2™ progressive lenses by ZEISS are carefully engineered around the visual and physiological requirements of the wearer. When paired with Transitions lenses they provide unsurpassed visual acuity and comfort, while helping to preserve healthy sight by blocking 100 percent of UVA and UVB rays.

Eyewear customers and eye care professionals will benefit from a promotional campaign to support the award winning GT2™ by ZEISS. Eyewear customers who visit a ZEISS Certified Practice between now and the end of the year, can enter to win special prizes. Eyecare professionals in 16 select city regions will receive matching incentives as part of the promotion.

ZEISS and Transitions lenses represent the best of vision care and complement one another to provide a superior product as well as setting the industry standard for customer service, product education and support.

Visit http://w
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Visionary Undertaking for Global E-Health Education
2. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
3. Abt Associates Names Dr. Scott W. Royal to Lead Domestic Health Division
4. Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship
5. The Help Groups Teddy Bear Ball Salutes Sony Pictures Television President, Steve Mosko and Features Performance by Kenny Loggins
6. Centenarians Vision Restored With New Sutureless Corneal Transplant Technology
7. U.S. Department of Education Funded Study Demonstrates, WordWorld, a PBS KIDS(R) Television Series Works as Critical Early Literacy Tool
8. LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group
9. Brand New Reality Series Follows the Emotional Journey of Five Friends as They Attempt to Go From Fat to Fit on DietTribe Premiering January 5th on Lifetime Television
10. PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers
11. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 As Stryker ... Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount ... new research has found a connection between the type of ... The study, which was published on May 15th in ... hips in 11 patients who reported new-onset and increasing ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Diabetes is ... it can become a nuisance when patients are unfortunate ... According to the National Diabetes Information Clearinghouse at ... at a risk of developing neuropathy which further shrivels ... lives of such patients. Such nerve damage affects the ...
(Date:5/23/2013)... SLEEPY HOLLOW, NY (PRWEB) May 23, 2013 ... joined the staff of Phelps Memorial Hospital Center as ... She will direct comprehensive inpatient and outpatient rehabilitation ... life. , Dr. Liu received her undergraduate degree in ... Scholar for four years. She earned her medical ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Statins are proven ... the medications also could hamper heart patients, ability to ... A small group of overweight or obese people were ... a 40 milligram daily dose of simvastatin, while another ... exercise regimen did show improvement, found the study released ...
(Date:5/23/2013)... (May 23, 2013) -- Little is known about why ... response to treatments varies between patients. Now, a team ... Medical Center and SUNY Downstate Medical Center has revealed ... showing that it is very different from other asthma ... , reveals that an over-active gene linked in 20 ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 3
... Johna Burke will describe communication tactics that can ... delivered on Tuesday, Jan. 6, at a professional ... of the International Association of Business Communicators (IABC). ... website ( www.sc-iabc.com ) or from Stefanie Caraviello ...
... Care Action Network (SCAN(R)) Health Plan Arizona, a nonprofit Medicare ... to train more than 60 seasoned van drivers about what ... a senior." SCAN has been focused on the unique needs ... to enhancing awareness and skills in the community in dealing ...
... Calif., January 5, 2008Scientists at Burnham Institute for Medical ... protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring ... DNA repair. Since Ddk is often deregulated in human ... damage control could help shape new cancer therapies. The ...
... 5, 2009 Only 17 percent of Spanish-speaking women ... a multivitamin containing folic acid daily, according to the ... on this population. , Folic acid can prevent ... brain and spine such as spina bifida and anencephaly, ...
... experts at the University of Cincinnati (UC) have identified a ... drug therapies to combat lung cancer. , The study, led ... of Molecular and Cellular Biology . , Proto-oncogenes ... (turnover of cells and tissue) but, when genetically modified, can ...
... ignition gadget prevents calls or texting while driving , , ... that prevents teens from talking on cell phones or ... of Utah researchers. , The Key2SafeDriving system includes ... connects wirelessly with the user,s cell phone via either ...
Cached Medicine News:Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 2Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 3Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 2Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 3Health News:Burnham researchers illuminate mechanisms that regulate DNA damage control and replication 2Health News:Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says 2Health News:Cell biologists identify new tumor suppressor for lung cancer 2Health News:Car Key Device Jams Teens' Cell Phones 2
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... May 22, 2013  The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®.  The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...
... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance).  The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...
Cached Medicine Technology:The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 2New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 3New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 4New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 5New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 7New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 8New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 9New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 10
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Inquire...
... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
... PRISM 7000 Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... accumulated PCR product is made possible ... and application-specific software in a single ...
Medicine Products: